Urinary bladder inflammation induces changes in urothelial nerve growth factor and TRPV1 channels

British Journal of Pharmacology

Volumn 172, Issue 7, 2015, Pages 1691-1699

  Coelho, A ^a,b   Wolf Johnston, A S ^c   Shinde, S ^c   Cruz, C D ^a,b   Cruz, F ^b,d   Avelino, A ^a,b   Birder, Lori A ^c  

^a University of Porto   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d HOSPITAL DE SÃO JOÃO   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; CAPSAICIN; CHELERYTHRINE; NERVE GROWTH FACTOR; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PROTEIN TYROSINE KINASE A; PROTEIN TYROSINE KINASE A ANTAGONIST; PROTEIN TYROSINE KINASE A INHIBITOR; PROTEIN TYROSINE KINASE INHIBITOR; RECEPTOR BLOCKING AGENT; UNCLASSIFIED DRUG; VANILLOID RECEPTOR 1; CYCLOPHOSPHAMIDE; PHOSPHATIDYLINOSITOL 3 KINASE; TRPV1 PROTEIN, RAT; VANILLOID RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLADDER MUCOSA; CELL CULTURE; CELL MEMBRANE; CONTROLLED STUDY; FEMALE; IN VIVO STUDY; NONHUMAN; PAIN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPRAGUE DAWLEY RAT; URINARY BLADDER INFLAMMATION; URINARY TRACT INFLAMMATION; UROTHELIUM; ANIMAL; ANTAGONISTS AND INHIBITORS; CHEMICALLY INDUCED; CYSTITIS; DRUG EFFECTS; METABOLISM;

ADENOSINE TRIPHOSPHATE; ANIMALS; CAPSAICIN; CELL MEMBRANE; CELLS, CULTURED; CYCLOPHOSPHAMIDE; CYSTITIS; FEMALE; NERVE GROWTH FACTOR; PAIN; PHOSPHATIDYLINOSITOL 3-KINASES; RATS, SPRAGUE-DAWLEY; RECEPTOR, TRKA; TRPV CATION CHANNELS; UROTHELIUM;

EID: 84924916268     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/bph.12958     Document Type: Article

References (50)

1. Alexander SPH, Benson HE, Faccenda E, Pawson AJ, Sharman JL, Catterall WA, et al. (2013a). The Concise Guide to PHARMACOLOGY 2013/14: Ion Channels. Br J Pharmacol 170: 1607-1651.
2. Alexander SPH, Benson HE, Faccenda E, Pawson AJ, Sharman JL, Spedding M, et al. (2013b). The Concise Guide to PHARMACOLOGY 2013/14: Enzymes. Br J Pharmacol 170: 1797-1867.
3. Allen SJ, Dawbarn D, (2006). Clinical relevance of the neurotrophins and their receptors. Clin Sci 110: 175-191.
4. Apsel B, Blair JA, Gonzalez B, Nazif TM, Feldman ME, Aizenstein B, et al. (2008). Targeted polypharmacology: discovery of dual inhibitors of tyrosine and phosphoinositide kinases. Nat Chem Biol 4: 691-699.
5. Auge C, Chene G, Dubourdeau M, Desoubzdanne D, Corman B, Palea S, et al. (2013). Relevance of the cyclophosphamide-induced cystitis model for pharmacological studies targeting inflammation and pain of the bladder. Eur J Pharmacol 707: 32-40.
6. Avelino A, Cruz C, Nagy I, Cruz F, (2002). Vanilloid receptor 1 expression in the rat urinary tract. Neuroscience 109: 787-798.
7. Ayar A, Ozcan M, Alcin E, Serhatlioglu I, Ozcan S, Kutlu S, et al. (2014). Oxytocin activates calcium signaling in rat sensory neurons through a protein kinase C-dependent mechanism. J Physiol Biochem 70: 43-48.
8. Beckel JM, Birder LA, (2012). Differential expression and function of nicotinic acetylcholine receptors in the urinary bladder epithelium of the rat. J Physiol 590 (Pt 6): 1465-1480.
9. Birder LA, (2010). Urothelial signaling. Auton Neurosci 153: 33-40.
10. Birder LA, Kanai AJ, de Groat WC, Kiss S, Nealen ML, Burke NE, et al. (2001). Vanilloid receptor expression suggests a sensory role for urinary bladder epithelial cells. Proc Natl Acad Sci U S A 98: 13396-13401.
11. Bjorling DE, Wang ZY, Bushman W, (2011). Models of inflammation of the lower urinary tract. Neurourol Urodyn 30: 673-682.
12. Bonnington JK, McNaughton PA, (2003). Signalling pathways involved in the sensitisation of mouse nociceptive neurones by nerve growth factor. J Physiol 551 (Pt 2): 433-446.
13. Boucher M, Meen M, Codron JP, Coudore F, Kemeny JL, Eschalier A, (2000). Cyclophosphamide-induced cystitis in freely-moving conscious rats: behavioral approach to a new model of visceral pain. J Urol 164: 203-208.
14. Caterina MJ, Schumacher MA, Tominaga M, Rosen TA, Levine JD, Julius D, (1997). The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature 389: 816-824.
15. Charrua A, Cruz CD, Cruz F, Avelino A, (2007). Transient receptor potential vanilloid subfamily 1 is essential for the generation of noxious bladder input and bladder overactivity in cystitis. J Urol 177: 1537-1541.
16. Charrua A, Reguenga C, Cordeiro JM, Correiade-Sa P, Paule C, Nagy I, et al. (2009). Functional transient receptor potential vanilloid 1 is expressed in human urothelial cells. J Urol 182: 2944-2950.
17. Chuang YC, Fraser MO, Yu Y, Chancellor MB, de Groat WC, Yoshimura N, (2001). The role of bladder afferent pathways in bladder hyperactivity induced by the intravesical administration of nerve growth factor. J Urol 165: 975-979.
18. Cruz CD, (2014). Neurotrophins in bladder function: what do we know and where do we go from here? Neurourol Urodyn 33: 39-45.
19. Dang K, Bielefeldt K, Gebhart GF, (2013). Cyclophosphamide-induced cystitis reduces ASIC channel but enhances TRPV1 receptor function in rat bladder sensory neurons. J Neurophysiol 110: 408-417.
20. Dinis P, Charrua A, Avelino A, Cruz F, (2004). Intravesical resiniferatoxin decreases spinal c-fos expression and increases bladder volume to reflex micturition in rats with chronic inflamed urinary bladders. BJU Int 94: 153-157.
21. Dornelles FN, Andrade EL, Campos MM, Calixto JB, (2014). Role of CXCR2 and TRPV1 in functional, inflammatory and behavioural changes in the rat model of cyclophosphamide-induced haemorrhagic cystitis. Br J Pharmacol 171: 452-467.
22. Frias B, Charrua A, Avelino A, Michel MC, Cruz F, Cruz CD, (2012). Transient receptor potential vanilloid 1 mediates nerve growth factor-induced bladder hyperactivity and noxious input. BJU Int 110 (8 Pt B): E422-E428.
23. Frias B, Allen S, Dawbarn D, Charrua A, Cruz F, Cruz CD, (2013). Brain-derived neurotrophic factor, acting at the spinal cord level, participates in bladder hyperactivity and referred pain during chronic bladder inflammation. Neuroscience 234: 88-102.
24. Guerios SD, Wang ZY, Boldon K, Bushman W, Bjorling DE, (2008). Blockade of NGF and trk receptors inhibits increased peripheral mechanical sensitivity accompanying cystitis in rats. Am J Physiol Regul Integr Comp Physiol 295: R111-R122.
25. Herbert JM, Augereau JM, Gleye J, Maffrand JP, (1990). Chelerythrine is a potent and specific inhibitor of protein kinase C. Biochem Biophys Res Commun 172: 993-999.
26. Homma Y, Nomiya A, Tagaya M, Oyama T, Takagaki K, Nishimatsu H, et al. (2013). Increased mRNA expression of genes involved in pronociceptive inflammatory reactions in bladder tissue of interstitial cystitis. J Urol 190: 1925-1931.
27. Jung EJ, Kim DR, (2008). Apoptotic cell death in TrkA-overexpressing cells: kinetic regulation of ERK phosphorylation and caspase-7 activation. Mol Cells 26: 12-17.
28. Kullmann FA, Shah MA, Birder LA, de Groat WC, (2009). Functional TRP and ASIC-like channels in cultured urothelial cells from the rat. Am J Physiol Renal Physiol 296: F892-F901.
29. Liu BL, Yang F, Zhan HL, Feng ZY, Zhang ZG, Li WB, et al. (2014). Increased severity of inflammation correlates with elevated expression of TRPV1 nerve fibers and nerve growth factor on interstitial cystitis/bladder pain syndrome. Urol Int 92: 202-208.
30. Liu HT, Kuo HC, (2007). Intravesical botulinum toxin A injections plus hydrodistension can reduce nerve growth factor production and control bladder pain in interstitial cystitis. Urology 70: 463-468.
31. Liu HT, Tyagi P, Chancellor MB, Kuo HC, (2009). Urinary nerve growth factor level is increased in patients with interstitial cystitis/bladder pain syndrome and decreased in responders to treatment. BJU Int 104: 1476-1481.
32. Lowe EM, Anand P, Terenghi G, Williams-Chestnut RE, Sinicropi DV, Osborne JL, (1997). Increased nerve growth factor levels in the urinary bladder of women with idiopathic sensory urgency and interstitial cystitis. Br J Urol 79: 572-577.
33. Mantyh PW, Koltzenburg M, Mendell LM, Tive L, Shelton DL, (2011). Antagonism of nerve growth factor-TrkA signaling and the relief of pain. Anesthesiology 115: 189-204.
34. Morenilla-Palao C, Planells-Cases R, Garcia-Sanz N, Ferrer-Montiel A, (2004). Regulated exocytosis contributes to protein kinase C potentiation of vanilloid receptor activity. J Biol Chem 279: 25665-25672.
35. Nazif O, Teichman JM, Gebhart GF, (2007). Neural upregulation in interstitial cystitis. Urology 69 (4 Suppl.): 24-33.
36. Obata K, Noguchi K, (2004). MAPK activation in nociceptive neurons and pain hypersensitivity. Life Sci 74: 2643-2653.
37. Parsons CL, (2004). Diagnosing chronic pelvic pain of bladder origin. J Reprod Med 49 (3 Suppl.): 235-242.
38. Pawson AJ, Sharman JL, Benson HE, Faccenda E, Alexander SP, Buneman OP, et al.; NC-IUPHAR (2014). The IUPHAR/BPS Guide to PHARMACOLOGY: an expert-driven knowledge base of drug targets and their ligands. Nucl Acids Res 42 (Database Issue): D1098-D1106.
39. Pezet S, McMahon SB, (2006). Neurotrophins: mediators and modulators of pain. Annu Rev Neurosci 29: 507-538.
40. Pinto R, Lopes T, Frias B, Silva A, Silva JA, Silva CM, et al. (2010). Trigonal injection of botulinum toxin A in patients with refractory bladder pain syndrome/interstitial cystitis. Eur Urol 58: 360-365.
41. Sadananda P, Kao FC, Liu L, Mansfield KJ, Burcher E, (2012). Acid and stretch, but not capsaicin, are effective stimuli for ATP release in the porcine bladder mucosa: are ASIC and TRPV1 receptors involved? Eur J Pharmacol 683: 252-259.
42. Saitoh C, Yokoyama H, Chancellor MB, de Groat WC, Yoshimura N, (2010). Comparison of voiding function and nociceptive behavior in two rat models of cystitis induced by cyclophosphamide or acetone. Neurourol Urodyn 29: 501-505.
43. Steers WD, Tuttle JB, (2006). Mechanisms of disease: the role of nerve growth factor in the pathophysiology of bladder disorders. Nat Clin Pract Urol 3: 101-110.
44. Stein AT, Ufret-Vincenty CA, Hua L, Santana LF, Gordon SE, (2006). Phosphoinositide 3-kinase binds to TRPV1 and mediates NGF-stimulated TRPV1 trafficking to the plasma membrane. J Gen Physiol 128: 509-522.
45. Vizzard MA, (2000). Changes in urinary bladder neurotrophic factor mRNA and NGF protein following urinary bladder dysfunction. Exp Neurol 161: 273-284.
46. Yoshimura N, de Groat WC, (1999). Increased excitability of afferent neurons innervating rat urinary bladder after chronic bladder inflammation. J Neurosci 19: 4644-4653.
47. Zhang Q, Descamps O, Hart MJ, Poksay KS, Spilman P, Kane DJ, et al. (2014). Paradoxical effect of TrkA inhibition in Alzheimer's disease models. J Alzheimers Dis 40: 605-617.
48. Zhang QL, Qiao LY, (2012). Regulation of IGF-1 but not TGF-beta1 by NGF in the smooth muscle of the inflamed urinary bladder. Regul Pept 177: 73-78.
49. Zhang X, Huang J, McNaughton PA, (2005). NGF rapidly increases membrane expression of TRPV1 heat-gated ion channels. EMBO J 24: 4211-4223.
50. Zhuang ZY, Xu H, Clapham DE, Ji RR, (2004). Phosphatidylinositol 3-kinase activates ERK in primary sensory neurons and mediates inflammatory heat hyperalgesia through TRPV1 sensitization. J Neurosci 24: 8300-8309.